Drug development usually scales up tens to thousands or even tens of thousands of times from laboratory processes to large-scale commercial production, and changes in the process may result in product disqualification, significantly prolonged production cycles, reduced product yields and even safety incidents. To reduce or avoid the issues above, PharmaResources has built an engineering scale-up technology platform.